Genedrive Launches Discounted Retail Share Offer to Fuel Expansion

Genedrive ( (GB:GDR) ) has provided an update.

Genedrive PLC has announced a conditional retail offer of new ordinary shares through RetailBook, priced at a 17.8% discount to the previous day’s closing price. The offer aims to raise additional working capital to support the company’s expansion efforts, including the anticipated CE-IVD certification of its CYP2C19 test, which will facilitate international sales. The RetailBook Offer is open to existing UK shareholders and is part of a broader fundraising strategy expected to generate £1.0 million in gross proceeds. This initiative reflects Genedrive’s commitment to engaging its retail shareholder base and leveraging new commercial opportunities.

More about Genedrive

Genedrive PLC operates in the healthcare industry, focusing on point-of-care pharmacogenetic testing. The company is known for its innovative genetic testing solutions, which are designed to provide rapid and accurate results at the point of care. Genedrive is actively pursuing commercial opportunities both in the UK and internationally, with a particular interest in expanding its market presence in the Middle East.

YTD Price Performance: -25.51%

Average Trading Volume: 2,988,867

Technical Sentiment Signal: Strong Buy

Current Market Cap: £9.91M

See more insights into GDR stock on TipRanks’ Stock Analysis page.